CStone Pharmaceuticals (CStone Pharma) has notified the market that its board of directors will convene on 27 August 2026.

The agenda includes: 1. Reviewing and approving the unaudited interim financial results for the six months ended 30 June 2026. 2. Authorising the public release of the interim results. 3. Considering the declaration and payment of an interim dividend, if any.

The announcement, dated 6 August 2026, was signed by Chairman Dr. Wei Li. The current board comprises one executive director, two additional non-executive directors and three independent non-executive directors.